Jones R - Search Results

1

Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies.

El-Serag H, Becher A, Jones R. El-Serag H, et al. Among authors: jones r. Aliment Pharmacol Ther. 2010 Sep;32(6):720-37. doi: 10.1111/j.1365-2036.2010.04406.x. Aliment Pharmacol Ther. 2010. PMID: 20662774 Review.

2

Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study.

Dent J, Vakil N, Jones R, Bytzer P, Schöning U, Halling K, Junghard O, Lind T. Dent J, et al. Among authors: jones r. Gut. 2010 Jun;59(6):714-21. doi: 10.1136/gut.2009.200063. Gut. 2010. PMID: 20551454 Clinical Trial.

3

Approach to gastroesophageal reflux disease in primary care: Putting the Montreal definition into practice.

Flook N, Jones R, Vakil N. Flook N, et al. Among authors: jones r. Can Fam Physician. 2008 May;54(5):701-5. Can Fam Physician. 2008. PMID: 18474703 Free PMC article. Review.

4

Don't eat tomatoes: patient's self-reported experiences of causes of symptoms in gastro-oesophageal reflux disease.

Dibley LB, Norton C, Jones R. Dibley LB, et al. Among authors: jones r. Fam Pract. 2010 Aug;27(4):410-7. doi: 10.1093/fampra/cmq020. Epub 2010 Apr 20. Fam Pract. 2010. PMID: 20406788

5

Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease.

Bytzer P, Jones R, Vakil N, Junghard O, Lind T, Wernersson B, Dent J. Bytzer P, et al. Among authors: jones r. Clin Gastroenterol Hepatol. 2012 Dec;10(12):1360-6. doi: 10.1016/j.cgh.2012.06.030. Epub 2012 Jul 17. Clin Gastroenterol Hepatol. 2012. PMID: 22813439

6

Systematic review: the epidemiology of gastro-oesophageal reflux disease in primary care, using the UK General Practice Research Database.

El-Serag H, Hill C, Jones R. El-Serag H, et al. Among authors: jones r. Aliment Pharmacol Ther. 2009 Mar 1;29(5):470-80. doi: 10.1111/j.1365-2036.2008.03901.x. Epub 2008 Nov 25. Aliment Pharmacol Ther. 2009. PMID: 19035977 Review.

7

Clinical trial: oral colon-release parnaparin sodium tablets (CB-01-05 MMX) for active left-sided ulcerative colitis.

Celasco G, Papa A, Jones R, Moro L, Bozzella R, Surace MM, Naccari GC, Gasbarrini G. Celasco G, et al. Among authors: jones r. Aliment Pharmacol Ther. 2010 Feb 1;31(3):375-86. doi: 10.1111/j.1365-2036.2009.04194.x. Epub 2009 Nov 5. Aliment Pharmacol Ther. 2010. PMID: 19891665 Clinical Trial.

8

Healthcare seeking in gastro-oesophageal reflux disease: a qualitative study.

Jones R, Ballard K. Jones R, et al. Eur J Gastroenterol Hepatol. 2008 Apr;20(4):269-75. doi: 10.1097/MEG.0b013e3282f2a5bd. Eur J Gastroenterol Hepatol. 2008. PMID: 18334869

9

[The Montreal definition and classification of gastroesophageal reflux disease: a global, evidence-based consensus paper].

Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Globale Konsensusgruppe. Vakil N, et al. Among authors: jones r. Z Gastroenterol. 2007 Nov;45(11):1125-40. doi: 10.1055/s-2007-963633. Z Gastroenterol. 2007. PMID: 18027314 German.

10

The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus.

Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Global Consensus Group. Vakil N, et al. Among authors: jones r. Am J Gastroenterol. 2006 Aug;101(8):1900-20; quiz 1943. doi: 10.1111/j.1572-0241.2006.00630.x. Am J Gastroenterol. 2006. PMID: 16928254

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results